Health Condition 1: A15-A19- Tuberculosis
Conditions
Interventions
Intervention1: Not Applicable: Not Applicable
Control Intervention1: Not Applicable: Not Applicable
Sponsors
BIOMERIEUX SA
bioMerieux India Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: A person who meets at least one of the criteria below, classifying him/her as suspected of having M. tuberculosis disease (active TB): - AFB-positive smear microscopy - Positive nucleic acid amplification test (NAAT) for M. tuberculosis - Clinical signs/symptoms - Clinical imagery such as chest X-ray or CT scan compatible with active TB
Exclusion criteria
Exclusion criteria: 1. A person who has been on an anti-TB treatment for more than 15 days for the ongoing infection (for MDR-TB, this refers to the second-line treatment) 2. Pregnant women (self-reported) 3. A person who has received an anti-TNF treatment within the previous 3 months 4. A person who has had a TST in the previous 12 weeks 5. A person who has been diagnosed with a NTM infection 6. A person with positive HIV status, confirmed by a laboratory test or via a rapid test performed at time of inclusion or within one month prior to inclusion into this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity and positive percent agreement for the VIDAS TB IGRA assay. Timepoint: After 5 month of recruitment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not ApplicableTimepoint: Not Applicable | — |
Countries
Brazil, France, India, Italy, Mexico, South Africa, United Kingdom, United States of America
Contacts
Public ContactDr Camilla Rodrigues
PD Hinduja Hospital and Medical Research Centre
Outcome results
None listed